The diagnostic value of MR imaging in differentiating t staging of bladder cancer: A meta-analysis

Radiology

Volumn 286, Issue 2, 2018, Pages 502-511

  Huang, Li ^a   Kong, Qingcong ^a   Liu, Zhenzhen ^a   Wang, Jin ^a   Kang, Zhuang ^a   Zhu, Yeqing ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLADDER CANCER; CANCER STAGING; CLINICAL PROTOCOL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFUSION WEIGHTED IMAGING; HUMAN; IMAGE ANALYSIS; META ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; BLADDER TUMOR; PATHOLOGY; RECEIVER OPERATING CHARACTERISTIC; STANDARDS;

HUMANS; MAGNETIC RESONANCE IMAGING; NEOPLASM STAGING; ROC CURVE; SENSITIVITY AND SPECIFICITY; URINARY BLADDER NEOPLASMS;

EID: 85041487872     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2017171028     Document Type: Article

References (33)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58(2):71-96. https://doi.org/10.3322/CA.2007.0010
2. Josephson D, Pasin E, Stein JP. Superficial bladder cancer: part. 2. Management. Expert Rev Anticancer Ther 2007;7(4):567-581
3. Sherif A, Jonsson MN, Wiklund NP. Treatment of muscle-invasive bladder cancer. Expert Rev Anticancer Ther 2007;7(9):1279-1283.
4. Fisher MR, Hricak H, Tanagho EA. Urinary bladder MR imaging. Part II. Neoplasm. Radiology 1985;157(2):471-477.
5. Daneshmand S, Ahmadi H, Huynh LN, Dobos N. Preoperative staging of invasive bladder cancer with dynamic gadolinium-enhanced magnetic resonance imaging: results from a prospective study. Urology 2012;80(6): 1313-1318.
6. El-Assmy A, Abou-El-Ghar ME, Mosbah A, et al. Bladder tumour staging: comparison of diffusion-and T2-weighted MR imaging. Eur Radiol 2009;19(7):1575-1581.
7. Ghafoori M, Shakiba M, Ghiasi A, Asvadi N, Hosseini K, Alavi M. Value of MRI in local staging of bladder cancer. Urol J 2013;10(2):866-872.
8. Gupta N, Sureka B, Kumar MM, Malik A, Bhushan TB, Mohanty NK. Comparison of dynamic contrast-enhanced and diffusion weighted magnetic resonance image in staging and grading of carcinoma bladder with histopathological correlation. Urol Ann 2015;7(2):199-204.
9. Hayashi N, Tochigi H, Shiraishi T, Takeda K, Kawamura J. A new staging criterion for bladder carcinoma using gadolinium-enhanced magnetic resonance imaging with an endorectal surface coil: a comparison with ultrasonography. BJU Int 2000;85(1):32-36.
10. Kobayashi S, Koga F, Yoshida S, et al. Diagnostic performance of diffusion-weighted magnetic resonance imaging in bladder cancer: potential utility of apparent diffusion coefficient values as a biomarker to predict clinical aggressiveness. Eur Radiol 2011;21(10):2178-2186.
11. Ohgiya Y, Suyama J, Sai S, et al. Preoperative T staging of urinary bladder cancer: efficacy of stalk detection and diagnostic performance of diffusion-weighted imaging at 3T. Magn Reson Med Sci 2014;13(3):175-181.
12. Rabie E, Faeghi F, Izadpanahi MH, Dayani MA. Role of Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Staging of Bladder Cancer. J Clin Diagn Res 2016;10(4):TC01-TC05.
13. Rajesh A, Sokhi HK, Fung R, Mulcahy KA, Bankart MJ. Bladder cancer: evaluation of staging accuracy using dynamic MRI. Clin Radiol 2011;66(12):1140-1145.
14. Takeuchi M, Sasaki S, Ito M, et al. Urinary bladder cancer: diffusion-weighted MR imaging-accuracy for diagnosing T stage and estimating histologic grade. Radiology 2009;251(1):112-121.
15. Tekes A, Kamel I, Imam K, et al. Dynamic MRI of bladder cancer: evaluation of staging accuracy. AJR Am J Roentgenol 2005;184(1):121-127.
16. Wang HJ, Pui MH, Guo Y, et al. Multiparametric 3-T MRI for differentiating lowversus high-grade and category T1 versus T2 bladder urothelial carcinoma. AJR Am J Roentgenol 2015;204(2):330-334.
17. Wang Y, Li Z, Meng X, et al. Nonmuscle-invasive and Muscle-invasive Urinary Bladder Cancer: Image Quality and Clinical Value of Reduced Field-of-view Versus Conventional Single-shot Echo-planar Imaging DWI. Medicine (Baltimore) 2016;95(10):e2951.
18. Watanabe H, Kanematsu M, Kondo H, et al. Preoperative T staging of urinary bladder cancer: does diffusion-weighted MRI have supplementary value? AJR Am J Roentgenol 2009;192(5):1361-1366.
19. Wu LM, Chen XX, Xu JR, et al. Clinical value of T2-weighted imaging combined with diffusion-weighted imaging in preoperative T staging of urinary bladder cancer: a largescale, multiobserver prospective study on 3.0-T MRI. Acad Radiol 2013;20(8):939-946.
20. Yamada Y, Kobayashi S, Isoshima S, Arima K, Sakuma H, Sugimura Y. The usefulness of diffusion-weighted magnetic resonance imaging in bladder cancer staging and functional analysis. J Cancer Res Ther 2014;10(4):878-882.
21. Sherif MF. The value of diffusion weighted MR imaging in T staging and correlation with histological grading in urinary bladder cancer. Egypt J Radiol Nucl Med 2015;46(1):189-194.
22. Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 2015;4(1):1.
23. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 2009;151(4):W65-W94.
24. Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 2011;155(8):529-536.
25. Harbord RM, Whiting P. metandi: Metaanalysis of diagnostic accuracy using hierarchical logistic regression. Stata J 2009; 9(2):211-229.
26. Dwamena BA, Sylvester R, Carlos RC. Midas: A program for meta-analytical integration of diagnostic accuracy studies in Stata. Ann Arbor, Mich: Division of Nuclear Medicine, Department of Radiology, University of Michigan Medical School, 2007.
27. Zamora J, Abraira V, Muriel A, Khan K, Coomarasamy A. Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol 2006;6(1):31.
28. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21(11):1539-1558.
29. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in metaanalyses. BMJ 2003;327(7414):557-560.
30. Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol 2005;58(9):882-893.
31. Bar-Shalom R, Yefremov N, Guralnik L, et al. Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management. J Nucl Med 2003;44(8):1200-1209.
32. Antoch G, Saoudi N, Kuehl H, et al. Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET. J Clin Oncol 2004;22(21):4357-4368.
33. Zhai N, Wang YH, Zhu LM, et al. Sensitivity and Specificity of Diffusion-Weighted Magnetic Resonance Imaging in Diagnosis of Bladder Cancers. Clin Invest Med 2015;38(4):E173-E184.